Related Experiment Video

Updated: Jun 4, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer

Shahana Majid1, Sharanjot Saini, Altaf A Dar

  • 1Department of Urology, VA Medical Center and University of California San Francisco, USA.

Cancer Research
|February 19, 2011
PubMed

Insights

MicroRNA-205 (miR-205) suppresses Src-mediated oncogenic pathways in renal cancer by inhibiting Src family kinases (SFKs). This discovery highlights miR-205

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Src family kinases (SFKs) are crucial regulators of cellular processes and are implicated in various cancers.
  • SFKs' roles in cancer progression make them attractive therapeutic targets.
  • The specific role of microRNA-205 (miR-205) in regulating SFK-driven oncogenesis in renal cancer requires elucidation.

Purpose of the Study:

  • To investigate the role of miR-205 in inhibiting SFK-mediated oncogenic pathways in renal cancer.
  • To determine the effect of miR-205 on SFK expression and downstream signaling.
  • To evaluate the therapeutic potential of miR-205 in renal cancer.

Main Methods:

  • Quantitative real-time PCR and Western blotting to assess miR-205 and SFK expression.
  • Luciferase reporter assays to validate miR-205 targeting of SFK 3'-UTRs.
  • Overexpression studies of miR-205 in renal cancer cell lines (A498) and in vivo models.
  • Analysis of cell proliferation, cell cycle, apoptosis, migration, and invasion assays.

Main Results:

  • miR-205 expression is significantly suppressed in renal cancer tissues and cell lines, inversely correlating with SFK expression.
  • miR-205 directly targets and suppresses the expression of Src, Lyn, and Yes kinases.
  • Overexpression of miR-205 inhibits renal cancer cell proliferation, migration, invasion, and tumor growth by downregulating the ERK1/2, FAK, and STAT3 pathways, leading to G₀/G₁ cell-cycle arrest and apoptosis.

Conclusions:

  • miR-205 acts as a tumor suppressor in renal cancer by inhibiting SFK activity.
  • miR-205 demonstrates therapeutic potential for treating renal cancer through its ability to suppress proto-oncogenic SFKs.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...